WAVE LIFE SCIENCES LTD. Current Liabilities
WAVE LIFE SCIENCES LTD. (WVE) had Current Liabilities of $50.81 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-07-30
- 2026-06-30: Liabilities, Current $50.81M.
- 2026-03-31: Liabilities, Current $49.83M.
- 2025-12-31: Liabilities, Current $95.06M.
- 2025-09-30: Liabilities, Current $85.90M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $50.81M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $49.83M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $95.06M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $85.90M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $87.41M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $87.37M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $110.95M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $170.73M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $173.13M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $165.87M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $186.44M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $99.98M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $140.23M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $132.57M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $71.52M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $64.26M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $64.08M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $58.49M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $64.20M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $31.64M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $46.72M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $48.68M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $121.04M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $109.66M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $110.45M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $118.88M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $118.15M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $133.41M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $124.08M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $131.88M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $130.04M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $125.80M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $43.78M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $16.30M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $18.19M 10-K · filed 2019-03-01 | $19.62M 10-K · filed 2018-03-12 |
| 2017-09-30 | $15.12M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $15.55M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $14.07M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $12.15M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $11.43M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $8.65M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $3.77M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $3.82M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $3.47M 10-Q · filed 2015-12-17 | |
| 2014-12-31 | $882.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |